🇺🇸 FDA
Pipeline program

HBS-301 tablet

HBS-301-CL-302

Phase 3 small_molecule active

Quick answer

HBS-301 tablet for Idiopathic Hypersomnia is a Phase 3 program (small_molecule) at Harmony Biosciences Holdings with 1 ClinicalTrials.gov record(s).

Program details

Company
Harmony Biosciences Holdings
Indication
Idiopathic Hypersomnia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials